New award for acitretin capsules with avkare. Ordering period is 12/11/2022 - 12/10/2023 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79722D0037
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 97% complete
IDV ceiling
$11,948,015.35
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center awarded a single-award indefinite delivery contract to Avkare LLC for acitretin capsules, with a ceiling of $11,948,015.35, on December 11, 2022. The contract carries no set-aside. The ordering period runs from December 11, 2022 through December 10, 2023, with four one-year options extending through December 10, 2026. Place of performance is Pulaski, Tennessee. The originating solicitation, posted July 12, 2022 with an August 5, 2022 due date, sought a new pharmaceutical supply award. A modification implements Executive Order 14398 regarding discrimination and diversity, equity, and inclusion requirements. The contract is firm fixed price. Avkare operates as a pure prime contractor supplying generic medications to federal healthcare agencies including the Department of Veterans Affairs, Defense Logistics Agency, and other federal health systems through established pharmaceutical prime vendor programs. The vendor competes on an unrestricted, full-and-open basis without small business set-asides, leveraging demonstrated capability and pricing alone.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · Modification to implement EO 14398 DEI discrimination. $0
Add Subcontract Plan P00009 · Incorporate avkare's 2026 subk plan into contract. Plan effective 1/1/2026 - 12/31/2026. $0
Exercise an Option P00008 · Exercise the third option year for acitretin capsules contract 36E79722D0037 with avkare, LLC with no price changes. $0
Add Subcontract Plan P00007 · Incorporate avkare's 2025 subk plan into contract. Plan effective 1/3/2025 - 12/31/2025. $0
Exercise an Option P00006 · Exercise the second option year for acitretin capsules contract 36E79722D0037 with avkare, LLC with no price changes. $0
Supplemental Agreement for work within scope P00005 · Update to cost recovery fee (CRF) and submission of quarterly sales reports 36E79722D0037, avkare, LLC for acitretin capsules. $0
Add Subcontract Plan P00004 · Implement avkare, LLC 2024 subk plan. $0
Exercise an Option P00003 · Exercise the first option year for acitretin capsules contract 36E79722D0037 with avkare, LLC with no price changes. $0
Other Administrative Action P00002 · Incorporate updated dscsa language and requirements into VA national contract 36E79722D0037. $0
Add Subcontract Plan P00001 · Far 52.219-9 small business subcontracting plan. Incorporate avkare, LLC 2023 subk plan. $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36E79722D0037?

36E79722D0037 was awarded to Avkare LLC by National Acquisition Center (Headquarters) on December 11, 2022.

How much is contract 36E79722D0037 worth?

36E79722D0037's own ceiling is $11,948,015.

Who can order from contract 36E79722D0037?

36E79722D0037 is a single award indefinite delivery contract.

Was contract 36E79722D0037 competed?

The extent of competition for 36E79722D0037 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV